Is there any domestically produced cabozantinib? What is the domestic price?

Cabozantinib (Cabozantinib) is available only with a prescription, and treatment should be started and supervised by a doctor experienced in using cancer drugs. Cabozantinib is an anti-tumor (cancer) drug that interferes with the growth of cancer cells, which are eventually destroyed by the body.

Cabotinib capsules are used to treat medullary thyroid cancer that has spread to different parts of the body. Cabozantinib tablets are used alone to treat advanced renal cancer. It is also used in combination with nivolumab as a first-line treatment for advanced cancer. Cabozantinib is also used to treat a type of cancer called hepatocellular carcinoma in people who have been previously treated with other drugs (such as sorafenib). Cabozantinib is also used to treat differentiated thyroid cancer, which has spread to different parts of the body and in patients who can no longer receive radioactive iodine therapy or who have previously received other drug treatments (such as VEGFR-targeted therapy) with poor results.

The original drug Cabozantinib is not marketed in the country and therefore cannot be included in medical insurance. There is no domestic drug cabozantinib available on the market yet, and it may be in the clinical trial stage. The original cabozantinib drug marketed overseas includes Japanese, Turkish and European versions. The price of tablets may be more than 30,000 yuan, and the price of capsule preparations may be more than 40,000 yuan (prices may fluctuate due to exchange rates). There are also generic drugs produced in other countries overseas, and their pharmaceutical ingredients are basically the same as those of the original drugs. For example, the price of pharmaceuticals produced by Bangladeshi pharmaceutical factories may be more than 2,000 yuan (the price may fluctuate due to the exchange rate), which is relatively cheap.